Helmuth Gadner

Q: What Schools Are Affiliated With Helmuth Gadner

Helmuth Gadner is affiliated with the following schools: Medical University of Vienna, Hannover Medical School, University of Graz, University of Vienna, University of Münster, Children's University

Helmuth Gadner's AcademicInfluence.com Rankings

Helmuth Gadner

Philosophy

#6857

World Rank

#9967

Historical Rank

Logic

#3954

World Rank

#5189

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Helmuth Gadner's Degrees

PhD Medical Sciences University of Vienna
Doctorate Medicine University of Vienna

Why Is Helmuth Gadner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Helmuth Gadner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. (2000) (898)
Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. (2002) (753)
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. (2003) (720)
Contemporary classification of histiocytic disorders (1997) (713)
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. (2000) (681)
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood (1998) (617)
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. (2007) (536)
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995 (2000) (524)
HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. (1997) (477)
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. (2011) (475)
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000 (2010) (447)
A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. (2001) (436)
Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6‐year experience of a European cooperative trial (1988) (400)
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. (2001) (394)
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. (1997) (362)
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. (2011) (356)
Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. (2003) (348)
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. (1999) (346)
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. (2000) (337)
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (2008) (334)
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. (2004) (330)
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. (2013) (323)
Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. (2002) (311)
Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? (1996) (309)
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. (1995) (301)
Treatment strategy for disseminated langerhans cell histiocytosis (1994) (290)
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. (2008) (282)
Risk factors for diabetes insipidus in langerhans cell histiocytosis (2006) (271)
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. (2001) (270)
Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. (1996) (250)
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements (2003) (241)
Teratomas in infancy and childhood. (1998) (235)
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. (1998) (231)
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. (1999) (231)
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials (2005) (224)
Results and significance of six randomized trials in four consecutive ALL-BFM studies. (1990) (215)
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis (2005) (214)
MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. (2004) (210)
Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients (1988) (209)
Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis (2008) (209)
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. (1994) (203)
Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. (2000) (198)
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. (2001) (198)
Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. (1990) (186)
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study (2005) (185)
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. (1992) (182)
Current therapy for Langerhans cell histiocytosis. (1998) (180)
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. (2000) (171)
Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society. (1989) (166)
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. (1998) (165)
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. (1991) (163)
Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. (2001) (160)
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. (2002) (154)
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. (2000) (149)
Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors (1997) (149)
Validation of the German version of the Pediatric Quality of Life InventoryTM (PedsQLTM) in childhood cancer patients off treatment and children with epilepsy (2004) (145)
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. (2009) (144)
Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible (2008) (143)
Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection (1999) (143)
EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. (1996) (141)
Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93 (2001) (140)
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. (2000) (140)
Treatment of Langerhans cell histiocytosis--evolution and current approaches. (1994) (134)
Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. (2002) (125)
Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients (1999) (124)
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. (2008) (121)
Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. (1993) (121)
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. (2006) (120)
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group (2000) (116)
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. (2005) (115)
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: Report of the HD CWS‐96 trial (2008) (114)
LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. (1994) (113)
Langerhans cell histiocytosis in neonates (2005) (109)
Expression of a myeloid marker on TdT-positive acute lymphocytic leukemic cells: evidence by double-fluorescence staining. (1982) (109)
Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. (1994) (109)
Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. (1995) (108)
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). (1999) (108)
Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. (1994) (107)
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. (2003) (107)
Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. (2006) (104)
Using a children's book to prepare children and parents for elective ENT surgery: results of a randomized clinical trial. (2003) (103)
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial (2007) (103)
Prognostic impact of chromosomal aberrations in Ewing tumours (2002) (101)
Synovial sarcoma of childhood and adolescence. Report of the german CWS‐81 study (1993) (100)
Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: results of a longitudinal, multi-center study (2006) (100)
Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. (2008) (98)
Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. (1994) (97)
Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning (2005) (97)
Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. (2000) (97)
Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. (1992) (95)
CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease (2004) (93)
Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. (2008) (93)
Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors. (2008) (92)
Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation (2006) (92)
Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis (2004) (92)
X-linked Wiskott-Aldrich syndrome in a girl. (1998) (91)
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. (2003) (89)
Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children (2001) (88)
Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. (2007) (88)
Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT‐PCR: A preliminary evaluation (1998) (87)
Detection of tumour cells in peripheral blood and bone marrow from ewing tumour patients by rt‐pcr (1995) (87)
Quality of life in long-term childhood cancer survivors and the relation of late effects and subjective well-being (2004) (86)
Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. (2012) (85)
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors (1999) (85)
Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis (2004) (83)
Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny. (1998) (83)
Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. (1998) (82)
Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment (1999) (82)
Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation (2001) (81)
Molecular and Functional Characterization of the Urokinase Receptor on Human Mast Cells* (1997) (79)
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. (1997) (77)
Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow (1997) (77)
Pattern and course of neurodegeneration in Langerhans cell histiocytosis. (2008) (76)
Modulation of antigen expression in B‐cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug‐induced regulatory phenomenon. Results of the AIEOP‐BFM‐ALL‐FLOW‐MRD‐Study Group (2010) (76)
Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. (2012) (73)
Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. (2000) (73)
Risk of secondary leukemia after treatment with etoposide VP‐16) for Langerhans cell histiocytosis in Italian and Austrian‐German populations (1997) (73)
[The west-berlin therapy study of acute lymphoblastic leukemia in childhood--report after 6 years (author's transl)]. (1977) (71)
Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group (2009) (70)
Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer. (2007) (68)
Selective engraftment of donor CD4+25high FOXP3-positive T cells in IPEX syndrome after nonmyeloablative hematopoietic stem cell transplantation. (2009) (68)
Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria (2013) (67)
A Controlled Trial of Recombinant Human Granulocyte-macrophage Colony-stimulating Factor After Total-body Irradiation, High-dose Chemotherapy, and Autologous Bone-marrow Transplantation for Acute Lymphoblastic-leukemia Or Malignant-lymphoma (1992) (66)
Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. (1993) (65)
Chromosomal regions involved in the pathogenesis of osteosarcomas (2000) (65)
The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. (1996) (65)
Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation--sign of tumour cell revertance? (1997) (64)
Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. (2001) (64)
Experience in pediatric myelodysplastic syndromes. (1992) (64)
Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. (1993) (63)
Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation. (1994) (63)
Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection (2003) (62)
Prognostic significance of DNA di-tetraploidy in neuroblastoma. (2001) (61)
Central nervous system‐related permanent consequences in patients with Langerhans cell histiocytosis (2007) (60)
The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005 (2005) (60)
Selective IgA Deficiency in Children With Recurrent Parotitis of Childhood (2005) (59)
Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations. (1998) (58)
Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. (1995) (57)
Outcome of children with primary resistant or relapsed non‐Hodgkin lymphoma and mature B‐cell leukemia after intensive first‐line treatment: A population‐based analysis of the Austrian cooperative study group (2005) (57)
Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis (1993) (57)
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children (2007) (57)
Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96. (2001) (56)
Long‐term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria – A population‐based report of the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group (2009) (56)
Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children (2000) (55)
Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. (1995) (55)
Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kit. (1995) (54)
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold (2012) (54)
Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis (1995) (54)
Chromosomal regions involved in the pathogenesis of osteosarcomas. (1999) (54)
CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. (1991) (53)
G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability (1999) (52)
Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy. (2008) (52)
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I. (2009) (52)
Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop (2004) (51)
The phenotypic spectrum of histiocytosis X cells. (1988) (50)
Stool polymerase chain reaction for Helicobacter pylori detection and clarithromycin susceptibility testing in children. (2010) (50)
Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. (1989) (50)
Health-Related Quality of Life in Austrian Elementary School Children (2008) (50)
Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. (1990) (49)
Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89. (2003) (49)
CD99 (MIC2) expression in paediatric B‐lineage leukaemia/lymphoma reflects maturation‐associated patterns of normal B‐lymphopoiesis (1999) (48)
Osteosarcoma in very young children (2010) (48)
Treatment for soft tissue sarcoma in childhood and adolescence (2005) (48)
Expression of tumour necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) receptors and sensitivity to TRAIL‐induced apoptosis in primary B‐cell acute lymphoblastic leukaemia cells (2000) (48)
Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality (2003) (47)
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome (2017) (46)
Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis (1999) (46)
Key Treatment Questions in Childhood Acute Lymphoblastic Leukemia: Results in 5 Consecutive Trials Performed by the ALL-BFM Study Group From 1981 to 2000 (2013) (46)
Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature (2000) (46)
Acute lymphoblastic leukemia: current status of therapy in children. (1984) (45)
Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts (2005) (45)
Antithymocyte Globulin Pharmacokinetics in Pediatric Patients After Hematopoietic Stem Cell Transplantation (2005) (45)
Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: signs of subset expansion and stimulation. (1999) (44)
Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. (1989) (44)
Granulocyte Transfusions in Children and Young Adults: Does the Dose Matter? (2009) (44)
Heterogeneity of the T-cell receptor delta gene indicating subclone formation in acute precursor B-cell leukemias. (1995) (43)
Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness. (1996) (42)
Demonstration of the translocation der(16)t(1;16)(q12;q11.2) in interphase nuclei of ewing tumors (1996) (41)
Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL): A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group (2013) (41)
Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol (1999) (41)
Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantation (1999) (40)
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). (2005) (40)
Constitutional interstitial deletion of 11p11 and pericentric inversion of chromosome 9 in a patient with Wiedemann-Beckwith syndrome and hepatoblastoma. (1986) (40)
Advances in bone tumour treatment in 30 years with respect to survival and limb salvage. A single institution experience (2002) (40)
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. (2003) (40)
Detection of minimal residual disease identifies differences in treatment response between TALL and precursor BALL (2002) (40)
German cross-cultural adaptation of the Health Utilities Index and its application to a sample of childhood cancer survivors (2000) (39)
Mixed Lineage Leukemia–Rearranged Childhood Pro-B and CD10-Negative Pre-B Acute Lymphoblastic Leukemia Constitute a Distinct Clinical Entity (2006) (39)
Detection of disseminated tumor cells in neuroblastoma: 3 log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytology. (2003) (38)
Immunogenotype Changes Prevail in Relapses of Young Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia and Derive Mainly from Clonal Selection (2005) (38)
Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine‐mobilized blood (1996) (38)
B‐cell differentiation pattern of cutaneous lymphomas in infancy and childhood (1988) (37)
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials. (1998) (37)
[Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82]. (1986) (37)
Management of immune thrombocytopenic purpura in children. (2001) (36)
Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features. (1997) (36)
Expression of Tumour Necrosis Factor (TNF)-related Apoptosis-Inducing Ligand (TRAIL) Receptors and Sensitivity to TRAIL-induced Apoptosis in Primary B-cell Acute Lymphoblastic Leukaemia Cells (2000) (35)
Conventional vs. liposomal amphotericin B in immunosuppressed children. (1992) (35)
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation. (1993) (35)
Bone marrow assessment in Langerhans cell histiocytosis (2007) (34)
Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall (2006) (33)
CMV-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease. (1998) (33)
Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. (2000) (33)
Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. (2004) (33)
Long‐term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis (2012) (33)
[Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study]. (1987) (33)
Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors. (2003) (33)
Histiocytosis following T-acute lymphoblastic leukemia: A BFM study (2005) (33)
Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children. (1994) (32)
Non‐random integration of epstein‐barr virus in lymphoblastoid cell lines (1993) (32)
Manifestations of Graft-Versus-Host Disease following Allogenic Bone Marrow Transplantation (1991) (31)
[The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl)]. (1981) (31)
Peripheral blood hematopoietic progenitor cells of cytokine-stimulated healthy donors as an alternative for allogeneic transplantation. (1994) (30)
Pathogenesis, biology, and management of myelodysplastic syndromes in children. (1996) (30)
Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy response. (2002) (30)
Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. (1992) (30)
Neuroblastoma cells provoke Schwann cell proliferation in vitro. (2001) (30)
Feasibility and Toxicity of Intrathecal Liposomal Cytarabine in 5 Children and Young Adults With Refractory Neoplastic Meningitis (2007) (29)
Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative? (1997) (29)
Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure. (1995) (29)
The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005 (2006) (29)
Response of Ewing tumor cells to forced and activated p53 expression (2003) (29)
Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia (2007) (29)
Concurrent Langerhans cell histiocytosis and myelodysplasia in children. (2000) (28)
A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma. (1992) (28)
Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours (1999) (27)
Detection of Residual Disease in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia by Comparative Phenotype Mapping: Method and Significance (2000) (27)
Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis (2000) (27)
The EWS protein is dispensable for Ewing tumor growth. (2001) (27)
First experience with prognostic factors in unselected neuroblastoma patients. The Austrian Neuroblastoma 87 Study. (1995) (25)
Amphotericin B serum levels in pediatric bone marrow transplant recipients. (1991) (25)
Clinical characteristics and treatment outcome of infants with non‐Hodgkin lymphoma (2007) (25)
IVIG Treatment of Adenovirus Infection-Associated Macrophage Activation Syndrome in a Two-Year-Old Boy: Case Report and Review of the Literature (2003) (24)
Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. (1994) (24)
The role of surgery in the treatment of pediatric B-cell non-Hodgkin's lymphoma. (2002) (23)
Low frequency of clonotypic Ig and T‐cell receptor gene rearrangements in t(4;11) infant acute lymphoblastic leukaemia and its implication for the detection of minimal residual disease (2002) (23)
Bone marrow transplant indications for childhood leukemias: Achieving a consensus (1996) (23)
Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: a study of five cases controlled by genetic methods. (1999) (23)
EARLY AND RELIABLE DIAGNOSIS OF NON-HODGKIN LYMPHOMA in CHILDHOOD AND ADOLESCENCE: Contribution of Cytomorphology and Flow Cytometric Immunophenotyping (2006) (23)
Glucocorticoids in the Treatment of Children with Acute Lymphoblastic Leukemia and Hodgkin's Disease: A Pilot Study on the Adverse Psychological Reactions and Possible Associations with Neurobiological, Endocrine, and Genetic Markers (2007) (23)
Rapid determination of Epstein–Barr virus latent or lytic infection in single human cells using in situ hybridization (2004) (23)
Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood (2015) (23)
Endocrine function after antineoplastic therapy in 22 children with acute lymphoblastic leukaemia. (1977) (22)
Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience. (2002) (21)
Ewing tumor after treatment of Ki-1+ anaplastic large cell lymphoma. Therapy-associated secondary neoplasm or unrelated coincidence? (1995) (21)
PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA. A PROSPECTIVE STUDY OF THE INTERNATIONL BFM STUDY GROUP. (1998) (21)
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy (2001) (21)
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The ‘big sister’ of the infant disease? (2007) (21)
Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis. (1999) (21)
A novel type of MLL/AF10 fusion transcript in a child with acute megakaryocytic leukemia (AML-M7) (1995) (21)
Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity? (1991) (21)
Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes. (2001) (20)
5q- chromosome in acute leukemia with lymphoid morphology and expression of myeloid membrane determinants. (1985) (20)
Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation. (1999) (20)
Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh GM-CSF) treatment of a patient in a continuous febrile state (1990) (20)
Prognostic relevance of dic(9;20)(p11;q13) in childhood B‐cell precursor acute lymphoblastic leukaemia treated with Berlin‐Frankfurt‐Münster (BFM) protocols containing an intensive induction and post‐induction consolidation therapy (2010) (19)
ENTEROVIRAL MENINGOENCEPHALITIS IN IMMUNOCOMPROMISED CHILDREN AFTER MATCHED UNRELATED DONOR-BONE MARROW TRANSPLANTATION (2000) (19)
NPM/ALK gene fusion transcripts identify a distinct subgroup of null type Ki‐1 positive anaplastic large cell lymphomas (1996) (19)
Treatment of germ cell tumors in children: results of European trials for testicular and non-testicular primary sites. (1990) (19)
Automatic detection and genetic profiling of disseminated neuroblastoma cells. (2001) (19)
High-resolution FISH of the entire integrated Epstein-Barr virus genome on extended human DNA. (1996) (19)
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time (2008) (19)
Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia. (1993) (19)
Bone marrow transplant indications for childhood leukemias: achieving a consensus. The EBMT Pediatric Diseases Working Party. (1996) (19)
Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients (1993) (19)
Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method : 115 000 screened infants in Austria (1996) (18)
Prognostic relevance of TLX3 (HOX11L2) expression in childhood T‐cell acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Münster (BFM) protocols containing early and late re‐intensification elements (2010) (18)
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group. (1993) (18)
Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia. (1987) (18)
REDUCTION IN TRANSFUSION REQUIREMENTS WITH EARLY EPOETIN ALFA TREATMENT IN PEDIATRIC PATIENTS WITH SOLID TUMORS: A Case-Control Study (2002) (18)
Near‐tetraploidy in childhood B‐cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1‐positive leukemic cases (2006) (18)
Characterization of Hematopoietic Stem Cells (1995) (18)
Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue. (1991) (18)
Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance. (2002) (18)
Does cord blood contain enough progenitor cells for transplantation? (1994) (18)
CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL FINDINGS IN FOUR CHILDREN WITH GASTROINTESTINAL STROMAL TUMORS OF THE STOMACH (2007) (18)
[Improved treatment results in children with AML: Results of study AML-BFM 93]. (2001) (17)
Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis. (2003) (17)
Crosslineage TCR delta rearrangements occur shortly after the DJ joinings of the IgH genes in childhood precursor B ALL and display age‐specific characteristics (1997) (17)
Collection efficiencies of MNC subpopulations during autologous CD34+ peripheral blood progenitor cell (PBPC) harvests in small children and adolescents (2001) (17)
Granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor for collection of peripheral blood progenitor cells from healthy donors (2000) (17)
Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma (1996) (17)
Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia. (2004) (17)
Treatment of severe aplastic anemia with combined immunosuppression (antithymocyte globulin and high-dose methylprednisolone). (1986) (17)
Expression of the putatively regulatory T-cell marker FOXP3 by CD4(+)CD25+ T cells after pediatric hematopoietic stem cell transplantation. (2006) (16)
In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation. (2005) (16)
High-dose melphalan, etoposide +/- carboplatin (MEC) combined with 12-gray fractionated total-body irradiation in children with generalized solid tumors. (1991) (16)
The Present Role of Bone Marrow and Stem Cell Transplantation in the Therapy of Children with Acute Leukemia (1997) (16)
The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children. (1990) (16)
Vertebra plana due to a Ewing tumor. (1999) (15)
Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene. (2006) (15)
Performance of a new separator system for routine autologous hematopoietic progenitor cell collection in small children (2007) (15)
Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma (2002) (15)
Alopecia areata and multifocal bone involvement in a young adult with Hodgkin's disease (2005) (15)
Proof of the reactive nature of the Schwann cell in neuroblastoma and its clinical implications. (1994) (15)
Vincristine (VCR) - Dexamethasone (DEXA) Pulses for Intermediate Risk (IR) Childhood Acute Lymphoblastic Leukemia (ALL) Treated with BFM Based Protocols: Results of the I-BFM-SG ALL IR 95 Study. (2005) (15)
Childhood acute lymphoblastic leukemia: results of the Austrian Cooperative Study Group with the ALL A 84 protocol. (1990) (15)
Interphase cytogenetic study of childhood acute lymphoblastic leukemia. (1994) (15)
European intergroup cooperative Ewing's sarcoma study (EICESS 92) (1998) (15)
Resolution of early cytomegalovirus (CMV) infection after leukocyte transfusion therapy from a CMV seropositive donor (1998) (15)
Partial nephrectomy in well-responding stage I Wilms' tumors: report of three cases. (1995) (15)
Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches – functional and prognastic information (2001) (14)
Langerhans cell granulomatosis. (1997) (14)
[Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study]. (1991) (14)
Toxic skin reaction restricted to palms and soles after high-dose methotrexate. (1991) (14)
Severe anemia owing to occult pulmonary hemorrhage: a diagnostic pitfall. (2006) (14)
Translocation (12;13) in a case of infantile fibrosarcoma. (1993) (14)
Acute leukemias express a functional receptor for the human growth hormone (1997) (14)
High-dose cyclophosphamide, adriamycin, and vincristine (HD-CAV) in children with recurrent solid tumor. (1994) (13)
Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients. (1994) (13)
Proposal for standard recommendations for prophylaxis of graft-versus-host disease in children. European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases and the International Study Committee of the BFM family-subcommittee Bone Marrow Transplantation (IBFM-STG). (1998) (13)
Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. (2002) (13)
Changes of CSF-protein pattern in children with acute lymphoblastic leukemia during prophylactic CNS therapy (Berlin protocol). (1980) (13)
Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases (1998) (13)
Dendritic Cells as Adjuvants in Antitumor Immune Therapy (2002) (13)
Cell-mediated immune functions in a patient with MHC class II deficiency. (1991) (13)
Isochromosome 12p and maternal loss of 1p36 in a pediatric testicular germ cell tumor. (1996) (13)
‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002 (2003) (13)
EQUAL FREQUENCY OF TEL/AML1 REARRANGEMENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA WITH AND WITHOUT DOWN SYNDROME (2005) (12)
Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors. (1996) (12)
Bone marrow transplantation during fulminant EBV-infection In Duncan's syndrome. (1993) (12)
Hepatitis B vaccination and immune response in children with malignant diseases (1985) (12)
Fresh frozen plasma contains free asparagine and may replace the plasma asparagine pool during L-asparaginase therapy (2008) (12)
Pediatric visceral leishmaniasis in Austria: diagnostic difficulties in a non-endemic region. (2001) (12)
Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children (2010) (12)
Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000. (2003) (11)
Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies. (2001) (11)
Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription (2003) (11)
Treatment of Ph-positive acute lymphoblastic leukemia with alpha-interferon. (1988) (11)
Immunoenzymatic staining methods for simultaneous demonstration of chromosomes and cell surface markers. (1987) (11)
Natural course of a Wilms' tumour (1999) (11)
Selection of CD34-Positive Blood Cells for Allogeneic Transplantation: Approaches to Optimize D34-Cell Recovery, Purity, Viability, and T-cell Depletion (2000) (11)
Langerhans' cell histiocytosis--still an unsolved problem. (1999) (10)
CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia (2007) (10)
Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group. (1995) (10)
Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation (2012) (10)
Wilms tumor and cardiomyopathy. (2003) (9)
Isolated cutaneous Langerhans cell histiocytosis in a premature baby: What is the optimal approach? (2013) (9)
Re: Is unifocal Langerhans cell histiocytosis of the orbit a “CNS‐risk” lesion? (2004) (9)
Cytochemically Myeloperoxidase Positive Childhood Acute Leukemia With Lymphoblastic Morphology Treated as Lymphoblastic Leukemia (2010) (9)
BIOV-111 a European Phase II Trial of Clofarabine (Evoltra®) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia. (2006) (9)
Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer (2005) (9)
Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Acute Lymphoblastic Leukemia (ALL) According to WBC Count, Age and TEL/AML1 Status at Diagnosis. Results of the AIEOP-BFM ALL 2000 Study. (2007) (9)
Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia (1995) (9)
Development of Curative Therapies for Ewing Sarcomas by Interdisciplinary Cooperative Groups in Europe (2015) (9)
Extramedullary plasmacytoma of the adenoids (2007) (8)
[The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)]. (1995) (8)
[Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81]. (1987) (8)
Cytogenetic studies in bone marrow transplant recipients (1986) (8)
Allogeneic Bone Marrow Transplantation for Childhood Acute Lymphoblastic Leukemia in Second Remission After Intensive Primary and Relapse Therapy (2003) (8)
Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia (2004) (8)
Extramedullary relapse despite graft-versus-leukemia effect after bone marrow transplantation in a girl with juvenile myelomonocytic leukemia. (1999) (8)
Neuroblastoma with N-myc amplification detected by urine: mass screening in infants after the sixth month of life. (1993) (8)
Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis. (2007) (8)
C7 Deficiency in Man (1975) (7)
Measuring health-related quality of life in children from different perspectives using the Pediatric Quality of Life Inventory™ (PedsQL™) and teachers’ ratings (2008) (7)
Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning (2011) (7)
Leukemia‐associated antigenic isoforms induce a specific immune response in children with T‐ALL (2006) (7)
[Acute leukemia in childhood]. (1991) (7)
Neuroblastoma: Impact of Biological Characteristics on Treatment Strategies (1995) (7)
Nodular pulmonary lesions in children after autologous stem cell transplantation: a source of misinterpretation (2008) (7)
MRD levels during the first months of treatment indicate relapses in children with t(12;21)-positive ALL (2000) (7)
Treatment of childhood acute nonlymphocytic leukemia: cooperative Austrian-Hungarian study AML-IGCI-84. (1990) (7)
Wilms' tumor and adrenocortical carcinoma with hemihypertrophy and hamartomas (1978) (7)
The TCCS—A short measure to evaluate treatment-related coping and compliance in hospitalised childhood cancer patients and their primary caregivers (2004) (7)
Treatment of adult-onset Langerhans cell histiocytosis--is it different from the pediatric approach? (2010) (7)
Recombinant human granulocyte-macrophage colony-stimulating factor in septic neutropenic pediatric cancer patients: detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery. (1995) (7)
Detecting disseminated solid tumor cells in hematopoietic samples: methodological aspects. (2001) (7)
Chromosome-Positive ( Ph 1 ) Childhood Acute Lymphoblastic Leukemia : Good Initial Steroid Response Allows Early Prediction of a Favorable Treatment Outcome (1998) (6)
T cell differentiation and generation of the antigen‐specific T cell repertoire in man: observations in MHC class II deficiency (1994) (6)
The treatment of childhood acute lymphoblastic leukemia - The International BFM Study Group experience (1998) (6)
Imperative of continual support by the European Community for future advances in paediatric oncology in Europe: meeting report of the EC-funded science-communication project DIRECT “Overcoming Cancer with Research” (2009) (6)
Early prednisone treatment and nephropathy in anaphylactoid purpura (1993) (6)
Pruritus in Pediatric Non-Hodgkin's Lymphoma (2002) (6)
VP-16 and the treatment of histiocytosis (1994) (6)
Influence of immunosuppression on acute liver toxicity after intensified conditioning regimens for bone marrow transplantation in children. (1991) (6)
Adrenocortical carcinoma with Ectopic LH production (2004) (6)
A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood. (1997) (6)
Prospective Study on Allogeneic Bone Marrow Transplantation (Allo BMT) versus Chemotherapy (Chemo) for Very High-Risk (VHR) Childhood Acute Lymphoblastic Leukaemia in First Complete Remission (2001) (6)
Permanent tunneled silicone central venous catheters for autologous PBPC harvest in children and young adults (2000) (6)
[The West-Berlin therapy study of acute lymphoblastic leukemia in childhood--report after 6 years]. (2013) (6)
Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115000 screened infants in Austria. (1997) (6)
Xenogenization by tetanus toxoid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomes. (2000) (6)
Chronic myelomonocytic leukemia (CMML) in childhood (1994) (6)
CD34 analysis in peripheral blood correlates with colony forming capacity--an update. (1992) (6)
Acute respiratory failure after intrathecal methotrexate administration. (1990) (6)
[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse]. (1982) (6)
Normal monocyte-derived dendritic cell function in patients with Langerhans-cell-histiocytosis. (2002) (5)
[Large cell anaplastic lymphoma in children--clinical experiences with a newly defined histologic entity]. (1989) (5)
Etoposide in Langerhans cell histiocytosis. (1996) (5)
[Treatment of chronic myeloid leukemia in children and adolescents--concept of the multicenter pilot study CML-ped]. (1996) (5)
Limited tolerance of intensified conditioning regimens in children receiving methotrexate/cyclosporin A for graft-versus-host disease prophylaxis. (1992) (5)
The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993. (1997) (5)
[Influence of dipropylacetic acid on hemostasis]. (1976) (5)
The median rise of leucocytes predicts the optimal days for leukapheresis in children. (1990) (5)
Autologous blood stem cell transplantation in pediatric cancer patients ‐ the austrian experience (1986–1991) (1992) (5)
Toxicity of tretinoin in acute promyelocytic leukaemia (1994) (5)
Relative enrichment of hematopoietic progenitor cells: efficiency of a repeated density centrifugation. (1991) (5)
Ondansetron in the control of chemotherapy-induced and radiotherapy-induced emesis in children with malignancies (1993) (5)
High-dose melphalan, etoposide, and carboplatin (MEC) +/- fractionated total body irradiation for treatment of advanced solid tumors. (1992) (4)
Comment on HLH in a child with anaplastic large cell lymphoma (ALCL). (2008) (4)
A case of the unstable Hb Genova (beta 28 Leu----Pro) in an Arab child associated with severe haemolytic anaemia and growth retardation. (1990) (4)
[Congenital syphilis: late diagnosis in spite of screening]. (1999) (4)
Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia (1986) (4)
Philadelphia chromosome‐positive mature B‐cell (Burkitt cell) leukaemia (2002) (4)
Demonstration of CD1a positive cells in the cerebrospinal fluid--A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic-pituitary axis? (2003) (4)
[Cytogenetic aspects of pediatric germ cell tumors]. (1995) (4)
Hutter C, Kauer M, Simonitsch-Klupp I et al.Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 120:5199-5208 (2012) (4)
Development of treatment and clinical results in childhood AML in Austria (1993–2013) (2014) (4)
Chromosomal aberrations in ewing tumors: An evaluation by conventional cytogenetics and in situ hybridization techniques (1996) (4)
Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL (2001) (4)
EQUAL FREQUENCY OF TEL/AML1+ ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN WITH AND WITHOUT DOWN SYNDROME (2005) (4)
Nonisotopic in situ hybridization for mapping oncogenic sequences. (1987) (3)
[Counting of platelets by means of an electronic counter in the hematologic service laboratory]. (1974) (3)
Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor. (1992) (3)
[5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas]. (1996) (3)
Is There Evidence-Based Benefit of Autologous Stem Cell Transplantation in Children with Solid Tumors? (2002) (3)
Ewing's tumor X mouse hybrids expressing the MIC2 antigen: analyses using fluorescence CDD-banding and non-isotopic ISH (2004) (3)
[Detection, quantification and characterization of disseminated tumor cells]. (2002) (3)
LCH I: A Randomized Trial of Treatment of Multisystem Langerhans Cell Histiocytosis (1999) (3)
[Treatment strategies in malignant non-Hodgkin lymphomas in childhood]. (1986) (3)
The impact of megatherapy on response and survival in high-risk Ewing's sarcoma. A report of the EBMT solid tumor registry (1992) (3)
Risk-Adapted Therapy and Randomization in Children with AML: Preliminary Results of Study AML-BFM 93 (2001) (3)
Allogeneic bone marrow transplantation-mediated transfer of specific immunity against Toxocara canis associated with excessive IgE (2001) (3)
Langerhans cell histiocytosis (2004) (3)
Prognostic Impact of Minimal Residual Disease (MRD) in Children Is Different in B or T Lineage Acute Lymphoblastic Leukemia: Results of Trial AIEOP-BFM ALL 2000. (2007) (3)
[Acute leukemia following exposure to chloramphenicol? Three case reports and review of the literature (author's transl)]. (1973) (3)
Survey of supportive care standards for paediatric allogeneic stem cell transplantation patients in Europe: a first report from the EBMT Paediatric Diseases Working Party. (1996) (3)
Chronic Myeloid Leukemia (CML) in Childhood - Results of the Multicenter-Trial CML-paed. (2004) (2)
Single and multicolor flow cytometric CD34 analysis in different cell sources. (1994) (2)
[Fibrin-fibrinogen split products during induction therapy of acute infantile leukemia]. (1979) (2)
Autologous rescue with blood-derived stem cells in a child with non-Hodgkin's lymphoma. (1990) (2)
[Electrolyte changes in acute leukemia in childhood]. (1985) (2)
Non-Hodgkin lymphomas (NHL) of childhood; treatment strategy and results in three multicenter trials of the BFM study grou (1991) (2)
[Cooperative studies in the treatment of acute lymphoblastic leukemia in children in Austria--report of 10 years' experience]. (1985) (2)
Orthopaedics and Haemophilia (1981) (2)
[Venous thrombosis of cranial sinuses in asparaginase therapy. A case report]. (1994) (2)
CSF-Protein Pattern before and During Induction Therapie of Acute Lymphoblastic Leukemia (1979) (2)
Survival and quality of life in 23 patients with severe aplastic anemia treated with bone marrow transplantation (BMT) (1987) (2)
Hemophagocytic syndrome with restricted organ involvement: excessive hemosiderosis and fibrosis of the spleen. (1986) (2)
[Wiedemann-Beckwith syndrome: clinical characteristics, constitutional chromosome abnormalities and tumor incidence]. (1987) (2)
Intestinal Adenovirus Infection With Increasing Viral Load in Stool is an Early Indicator of Impending Disseminated Disease in Children Undergoing Allogeneic Stem Cell Transplantation: 43 (2005) (2)
[The Netherton syndrome: clinical characteristics, differential diagnosis and new ways of therapy]. (1984) (2)
Variant alleles of cytokine genes influence risk and clinical course of Langerhans cell histiocytosis (2012) (2)
A Long Way from Definition of the Molecular Basis to Benefit in the Clinical Management of Ewing Tumours (1996) (2)
Prognostic Factors in CD10 Negative Precursor B-Cell Acute Lymphoblastic Leukemia in Children: Data from Three Consecutive Trials ALL-BFM 86, 90, and 95. (2004) (2)
The chest is the most frequent relapse site after ablative therapy and autologous stem cell rescue for poor prognosis Ewing's sarcoma (1992) (2)
[Veno-occlusive disease of the liver as a treatment complication in children with Wilm's tumor]. (1992) (2)
Is CD33 a differentiation marker? (1994) (2)
Non-atopic IgE and eosinophil cationic protein after allogeneic hematopoietic stem cell transplantation in children (2012) (2)
CD20 up-Regulation in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia during Induction Treatment Translates into Higher Rituximab-Sensitivity. (2008) (2)
Results of children with renal tumors treated in the Austrian–Hungarian Wilms Tumor Study 1989 and the International Society of Pediatric Oncology (SIOP) 93-01/GPOH trial in Austria (2012) (2)
[Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study]. (1996) (2)
More and better cure for an orphan: priorities for future paediatric cancer research in Europe – Meeting report of the EC-funded science-communication project DIRECT “Overcoming Cancer with Research” (2009) (2)
All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia. (1996) (2)
Preliminary results of the GPO-trial for treatment of non-testicular germ-cell tumors in children and adolescents. (1985) (2)
Heterogeneous TCR delta Vdelta2-Ddelta3 rearrangements and their relation to IgH and TCR gamma gene status in childhood B cell precursor leukaemias. (1999) (2)
Diagnostic specificity of the monoclonal anti-CALLA antibody VIL-A1 in leukemia and malignant lymphoma (1984) (2)
Heterogeneous TCR delta Vδ2-Dδ3 rearrangements and their relation to IgH and TCR gamma gene status in childhood B cell precursor leukaemias (1999) (2)
Intensified chemotherapy with ifosfamide (IFO) and influence of intraarterial (i.a.) versus intravenous (i.v.) infusion of cisplatinum (DDP). Preliminary results. (1990) (1)
Abstracts of the 12th European Colloquium on Cytogenetics of Domestic Animals (1996) (1)
Incidence of Secondary Leukemias After Therapy of Childhood Hodgkin’s Disease Without Nitrogen-Mustard. Results of the German-Austrian Study Group (1997) (1)
An international histiocytic language. (1995) (1)
Detection of minimal residual disease in T-ALL and in precursor-B-ALL (2001) (1)
Hodgkin's disease and a mediastinal tumor (1983) (1)
[Cytogenetic and molecular genetic changes in malignant primary bone tumors]. (1998) (1)
Aclacinomycin-A in the induction treatment of childhood AML. (1986) (1)
Unusually long survival after autografting in second partial remission of translocation t(4;11) acute infant leukemia. (1991) (1)
BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment. (1996) (1)
ITP in childhood: difficulties in the individual treatment. (1986) (1)
[Immunofluorescence and immunocytochemical stain methods for simultaneous cytogenetic and phenotypic characterization of mitotic cells]. (1989) (1)
Treatment Response and Outcome in Childhood t(1;19)/TCF3-PBX1 Positive Acute Lymphoblastic Leukemia: A Report from the Austrian BFM Group. (2005) (1)
The Life and Work of Professor Riehm from a Participant’s Perspective (2013) (1)
[Therapy of severe aplastic anemia (SAA) by bone marrow transplantation (BMT) or immunosuppression?]. (1987) (1)
[Results of neuroblastoma treatment in Austria (1979-1984)]. (1986) (1)
Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukaemia (2007) (1)
Bone Marrow Transplantation (BMT) for Severe Aplastic Anemia (SAA): Results Obtained in 19 Patients (1985) (1)
Chronic myelomonocytic leukemia (CMML) in childhood. (Abstract) (1994) (1)
Genetic Heterogeneity in Ewing Tumors and Neuroblastomas (1999) (1)
[Clinical applications of cytokines in pediatrics]. (1994) (1)
Evolution and Current Approaches (2007) (1)
Treatment of Relapsed Acute Lymphoblastic Leukemia (2003) (1)
Pediatric Experiences in Myelodysplastic Syndrome (1992) (1)
Surface glycoproteins (S-GP) on normal and malignant human leukocytes (1985) (1)
Generalized Lymphadenopathy in Juvenile Chronic Myelomonocytic Leukemia Is Due to Lymph Node Infiltration with Myelomonocytic Cells and Immature T Cells (1992) (1)
[Autologous peripheral stem cell transplantation in children]. (1989) (1)
Myelodysplasia in childhood. (1991) (1)
Group report event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Intensive ALL-type therapy without local radiotherapy provides a 90% (2013) (1)
Akute unilaterale Mydriasis (2008) (1)
Immunogenicity of Childhood T-ALL. (2006) (1)
Early prophylactic treatment with high-dose recombinant human erythropoetin (rHuEPO) in children with solid tumors (1999) (1)
An international histiocytic language [letter; comment] (1995) (1)
Suppression of EWS/FLI-1 oncogene function by transient transfection of dominant negative acting recombinant derivatives (1994) (1)
20 Multisystem Langerhans Cell Histiocytosis: progress in clinical management despite controversial biology (2009) (0)
Pre-Conference Statements: Schnabel, F.: The 1980s (1981) (0)
[Aseptic bone necroses in leukemia patients in childhood and adolescence]. (1987) (0)
Treatment for multisystem langerhans' cell histiocytosis [5] (multiple letters) (2002) (0)
Minimal residual disease analysis in children with t ( 12 ; 21 )-positive acute lymphoblastic leukemia : comparison of Ig / TCR rearrangements (2006) (0)
Molecular aspects in bone and soft tissue sarcomas (1995) (0)
[Diagnostic studies in congenital afibrinogenemia]. (1974) (0)
4114 POSTER Monitoring of Bone Marrow Clearing by an Automated Imaging Device (Immunofluorescence Plus Genetics) Identifies Different Risk Groups in Neuroblastoma Patients Over 18 Months (2011) (0)
[Current stage of leukemia treatment in children]. (1983) (0)
62: High Resolution HLA Typing and ATG Prevent Children with all from GVHD and Treatment Related Mortality After Unrelated Donor Stem Cell Transplantation (2008) (0)
Intensification of Chemotherapy Does Not Improve Prognosis of Standard Risk Patients Undergoing Therapy for Acute Myelogenous Leukemia: Results of the Pediatric Clinical Trial AML-BFM 98. (2004) (0)
The 12th Meeting of the European Society for Paediatric Haematology and Immunology (ESPHI) (2004) (0)
lymphoblastic leukemia indicates an in utero origin of diverse types of early childhood acute Presence of clone-specific antigen receptor gene rearrangements at birth (2013) (0)
[Cell proliferation and cell death in disseminated tumor cells]. (2002) (0)
The role of 1P36.3 in pediatric germ cell tumors (1996) (0)
childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study Late MRD response determines relapse risk overall and in subsets of (2013) (0)
Paediatric tumours — What have we learnt? General messages for oncologists (1999) (0)
[Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study]. (1989) (0)
[Progress in the treatment of juvenile leukemias]. (1982) (0)
[Phenotypic differences between CD34 positive cells in various transplantation tissues]. (1995) (0)
Achievements and Future Perspectives in the Treatment of Multisystem Langerhans Cell Histiocytosis (2005) (0)
Complete remission of 4 years following autologous blood stem cell transplantation in a child with early relapse of translocation t(9;X) acute lymphoblastic leukemia. (1992) (0)
Results in Children and Adolescents Treated According to Study AML-BFM 98: Less Toxic Deaths in the Short-Cycle Arm Than in the 6-Week Consolidation Arm. (2005) (0)
And the sun keeps shining. (2001) (0)
Book Reviews (1955) (0)
In vitro evaluation of a tumor vaccine based on the xenogenization of tumor cells with tetanus toxoid molecules (1999) (0)
associated with therapy intensification Improved outcome in multisystem Langerhans cell histiocytosis is (2013) (0)
The history of pediatric hematology and oncology in Austria. (1992) (0)
Treatment of Childhood Acute Nonlymphoblastic Leukemia — Final Results of the Austrian-Hungarian Study AML-IGCL-84 (1996) (0)
[The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors]. (1991) (0)
Subject Index, Vol. 76, 1986 (1986) (0)
Prognostic value of blasts on day 15 in bone marrow and of molecular evaluation of remission in children with acute lymphoblastic leukemia (1999) (0)
Home Treatment of Haemophilic Children Controlled by an External Nursing Service (1981) (0)
Ph~+儿童急性淋巴细胞性白血病:良好的类固醇初始反应可以早期预测较件的治疗结果 (2000) (0)
Lymphoblastic lymphoma and leukemia in children (2010) (0)
Subject Index Vol.28, 2001 (2001) (0)
RESPIRATORY VIRAL INFECTIONS IN YOUNG HOSPITALIZED CHILDREN AND OUTPATIENTS IN AUSTRIA. PRELIMINARY RESULTS OF A LONG TERM STUDY (1985) (0)
[Retinoblastoma--an interdisciplinary challenge]. (2006) (0)
Premature chromosome condensation pcc technique supplements cytogenetic and cytofluorometric dna analysis of acquired karyotype abnormalities in all (1991) (0)
Lessons learned from the analysis of P53 in familial and childhood cancer (1993) (0)
Interphase Cytogenetics of Childhood Acute Lymphoblastic Leukemia with Fluorescence In Situ Hybridization Using a Panel of Eight Chromosome-Specific DNA Probes (1994) (0)
Myeloablation, stem cell grafting and cytokine therapy in poor prognosis Ewing sarcoma : current concepts and future directions (1992) (0)
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia (2016) (0)
Cytokines, chemokines and gene expresion patterns in BAL fluid of children after stem cell transplantation (2010) (0)
expression of myeloid membrane determinants 5q- chromosome in acute leukemia with lymphoid morphology and (2011) (0)
Pre-Conference Statements: Maurer, M.H.: First International Haemophilia Conference (1981) (0)
Prognostic implications of tumor cell infiltration of the hematopoietic system in pediatric and adult tumor patients (1999) (0)
PCR as a Diagnostic Tool in ALL: A Comparison Between Cytogenetic and Polymerase Chain Reaction Analysis in Pediatric Patients with Acute Lymphoblastic Leukemia (1994) (0)
The harvesting of peripheral blood progenitor cells (PBPCs) after granulocyte colony-stimulating factor or granulocyte- macrophage colony-stimulating factor stimulation instead of bone marrow in healthy donors (0)
Bone marrow transplantation (BMT) for leukemia in children (1993) (0)
Neurological features of the CCFDN (congenital cataracts facial dysmorphism neuropathy)-syndrome (2004) (0)
Chairmen and Participants (1981) (0)
Subject Index Vol. 18, 1995 (1995) (0)
NNR carcinoma 4 years after a nephroblastoma on the same side: was this a radiation-induced second tumor (1973) (0)
NON TUMORAL DEATH (NTD) AFTER MEGATHERAPY (MGT) FOR NEUROBLASTOMA (NBL). THE EBMT EXPERIENCE (1994) (0)
Late effects and quality of life (2001) (0)
Results of a phase II trial (ST1571-CML-Ped) testing imatinib (Gleevec (TM), Glivec (TM)) in children with chronic myelogenous leukemia (CML). (2003) (0)
Flow-Cytometric Enumeration of CD34+ Cells: Comparison of a Conventional Lyse-and-Wash Method with Two Commercial Lyse-no-Wash Kits (2001) (0)
Diversity of the TcR-d Gene Rearrangements Indicates Subclone Formation in Acute B Cell Precursor Leukemias (1997) (0)
Initiation and progression of disease: Loss of heterozygosity at 1p during tumor progression in Ewing's tumors (1991) (0)
Neuroblastoma M ass S creening i n L ate I nfancy: Insights I nto t he B iology o f N euroblastic T umors (2003) (0)
Intensive chemotherapy and bone marrow transplantation for children with acute myeloid leukemia (2001) (0)
Incidence of TEL/AML1 fusion genes in children with ALL: risk assessment by BFM and MRD criteria (1999) (0)
RNAi Silencing of TEL-AML1 Reveals a Heat Shock Protein Dependent Mechanism in the Development of Leukemia. (2005) (0)
Recovery kinetics after chemotherapy and circulating mononuclear cells expressing the CD34 antigen in pediatric cancer patients (1992) (0)
hemophagocytic lymphohistiocytosis transplantation from the same haploidentical family donor in a girl with Successful stem cell transplantation following orthotopic liver (2013) (0)
Contents, Vol. 76, 1986 (1986) (0)
THE BERLIN-WEST ALL STUDY AFTER 7 YEARS AND ITS 3 YEARS' CONTROL IN MUNSTER/WESTFALEN AND FRANKFURT/MAIN (1978) (0)
[Malignant peripheral neuroepithelial tumors in childhood]. (1987) (0)
In memoriam Mildred Scheel (1985) (0)
Prognostic signiﬁcance and modalities of ﬂow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia minimal in (2002) (0)
Abstract 2478: Jagged 2 signalling is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells (2012) (0)
[Long-term monitoring of therapy-induced computerized tomographic cranial changes in children with acute lymphoblastic leukemia]. (1997) (0)
National Status Reports (Poster Presentation) (1981) (0)
Risk factors for the development of acute and chronic GvHD after allogeneic hematopoietic stem cell transplantation in children and adolescents (2005) (0)
Complete Contents Vol. 28, 2001 (2001) (0)
directed immunotherapy leukemia during induction treatment: setting the stage for anti-CD20 CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic (2008) (0)
Adverse Prognostic Factors in Stage-4 Neuroblastoma Over One-Year of Age - a Report From the European Bone-Marrow Transplantation Solid Tumor Registry (1994) (0)
[Coagulation proteins in cerebrospinal fluid in children with acute lymphoblastic leukemia during conbined induction therapy]. (1979) (0)
40 Undifferentiated disseminated NSE-positive sarcoma with double reciprocal translocation T(11;22) (22;21) (1987) (0)
transplantation hematopoietic stem cells after allogeneic bone marrow Origin of human mast cells: development from transplanted (2011) (0)
Questions and Answers – Workshop on Comprehensive Care (Workshop I) (2004) (0)
Markers Associations with Neurobiological , Endocrine , and Genetic Study on the Adverse Psychological Reactions and Possible Lymphoblastic Leukemia and Hodgkin ' s Disease : A Pilot Glucocorticoids in the Treatment of Children with Acute (2007) (0)
Neuroblastoma cells need normal cells for complete organogenic maturation (1994) (0)
[Allogeneic bone marrow transplantation in acute myeloid leukemia (AML): results in 14 patients]. (1987) (0)
5 DEFECTIVE PLATELET AGGREGATION IN CHILDREN WITH ALL DURING INDUCTION AND MAINTENANCE CHEMOTHERAPY (1979) (0)
TREATMENT OF CHILDHOOD ALL 3123 an increased leukemic cell (2002) (0)
Pcr-Screening for Viral Infections during Allogeneic Stem Cell Transplantation: Clinical Benefit and Economic Consideration. (2004) (0)
Monitoring and functional characterization of rare tumor cells in the haematopoietic system (1999) (0)
[Acute diabetic metabolic disorders during therapy of lymphoblastic leukemias]. (1974) (0)
[Rhabdomyosarcoma in childhood--presentation of a nation-wide Austrian study]. (1984) (0)
Pre-Conference Statements: Inwood; M.J.: The Haemophiliacs Blueprint of the Eighties (1981) (0)
Phenotypic and Genotypic Heterogeneity in Infant Acute Leukemia1 (Abstract) (1991) (0)
[Sarcoma botryoides in the pediatric vagina--a soft tissue sarcoma with good prognosis]. (1996) (0)
immuno-chemotherapy and bone marrow transplantation Treatment of hemophagocytic lymphohistiocytosis with HLH-94 (2013) (0)
Toxicity of tretinoin in acute promyelocytic leukaemia. (1994) (0)
Quantitative polymerase chain reaction for early detection of impending relapse and for the monitoring of remission in patients with chronic myeloid leukemia (1993) (0)
Modification of therapeutic strategies in rhabdomyosarcoma of the urinary bladder (1984) (0)
multisystem Langerhans Cell Histiocytosis (ms-lch): Predictive Value Of Scoring System Based On Risk-organ Involvement (ro) At Diagnosis (2015) (0)
LANGERHANS CELL GRANULOMATOSIS. AUTHORS' REPLY (1997) (0)
[Guidelines for therapy of idiopathic thrombocytopenic purpura (ITP) in childhood]. (1986) (0)
PROPOSAL FOR STANDARD RECOMMENDATIONS FOR PROPHYLAXIS OF GRAFT-VERSUS-HOSTDISEASE IN CHILDREN (1998) (0)
[Unexpected regeneration of a congenital unilateral hypoplastic- dysplastic kidney after a contralateral nephrectomy for Wilms tumor]. (1999) (0)
Haematology and Haemophilia (1981) (0)
Fractionated Total Body Irradiation or Busulfan in Combination with Etoposide and Cyclophosphamide as Conditioning Regimen for Bone Marrow Transplantation in Acute Leukemias in Children (1994) (0)
Upper And Lower Respiratory Tract Infections With Human Metapneumovirus In Immunocompromised Children (2010) (0)
Response: Design and reporting of clinical trials in LCH (2008) (0)
[Bone marrow transplantation for aplastic anemia--initial results in 8 patients]. (1982) (0)
Genetics and biology of neuroblastoma - an overview (2004) (0)
Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia. (2002) (0)
Prognostic F actors i n E wing's T umor o f B one: A nalysis o f 975 P atients F rom t he E uropean I ntergroup C ooperative Ewing's S arcoma S tudy G roup (2000) (0)
persistence of a preleukemic clone t(12;21)-positive acute lymphoblastic leukemia: evidence for the Late relapses evolve from slow-responding subclones in (2013) (0)
[Coagulation physiological studies during hypoxia and hypercapnia in young Göttingen miniature-pigs]. (1977) (0)
Childhood Acute Nonlymphoblastic Leukemia — Results of the Austrian-Hungarian Acute Myeloid Leukemia Studies IGCI-84 and 90 (1997) (0)
Biological properties of Ewing tumor derived cell lines (1989) (0)
[Persecuted and murdered pediatricians of Austria--a belated memorial]. (1999) (0)
Premature chromosome condensation technique an alternative form of interphase cytogenetics in childhood acute lymphoblastic leukemia (1991) (0)
A VNTR-sequence at 1P36 frequently deleted in solid tumours is amplified during normal differentiation (1996) (0)
Fluorescence in situ hybridization (FISH) combined with immunohistochemistry in neuroblastoma (1992) (0)
[Acute heart failure as an initial symptom of juvenile pheochromocytoma. Glucocorticoid therapy as a possible cause of normotension]. (1984) (0)
[Liposomal amphotericin B in the treatment of candida infection in a 3-month-old infant]. (1992) (0)
Offices of the Conference (1981) (0)
[Use of corticosteroids and immunoglobulins in acute and chronic immune thrombocytopenia in childhood. A clinically oriented treatment concept]. (1997) (0)
[Alteration of platelet function during intensive replacement therapy in haemophilia A (author's transl)]. (1977) (0)
Loss of interferon genes during tumor progression in Ewing tumors (1992) (0)
Electronic platelet counting with capillary blood samples—Experiences in a paediatric clinic (1978) (0)
A midi-satellite sequence at 1P36 frequently deleted in human tumors is amplified during normal differentiation (1997) (0)
5q - marker chromosome in acute leukemia with lymphoid morphology and myeloid differentiation antigens. (1985) (0)
Pre-Conference Statements: Egli, H.: The Bonn Conference (1981) (0)
Tumour cells can eliminate amplified genes (1999) (0)
[The diagnosis and strategy for the therapy of Langerhans-cell histiocytosis in childhood]. (1993) (0)
Micronuclei can contain amplified genes (1996) (0)
Questions and Answers – Workshop on Mobilizing Support for Haemophilia Care (Workshop II) (1981) (0)
Clonal Changes Are Frequent in Relapsed TEL-AML1+ ALL and Predominate in Young Children. (2004) (0)
Contents, Vol. 10, Supplement 1, 1981 (1981) (0)
[Bone marrow transplantation in chronic myeloid leukemia--experiences in 16 patients]. (1987) (0)
Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia. (1987) (0)
good outcome in childhood acute lymphoblastic leukemia Rapid molecular response during early induction chemotherapy predicts a (2013) (0)
Simultaneous cytogenetic and immunological characterization of mitotic blast cells (1986) (0)
Variability ofnm23-HJ/NDPK-A expression inhumanlymphomas andits relation totumour aggressiveness (1996) (0)
[Surface glycoproteins of normal and malignant leukocytes]. (1983) (0)
Detection of the multidrug resistance gene (MDR-1) expression by non-radioactive quantitative polymerase chain reaction (1993) (0)
ISH methods to detect structural and numerical genomic changes in paraffin embedded neuroblastomas (1993) (0)
[Definition of malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in children]. (1989) (0)
Change of risk factors for treatment-related mortality in children undergoing hematopoietic stem cell transplantation for malignant and nonmalignant diseases (2005) (0)
Free Papers (2014) (0)
Questions and Answers (Workshop III) (1981) (0)
Annual congress of the Austrian Society of Hematology and Oncology and the Hungarian Societies of Hematology and Oncology. Graz, 27-30 September 1992. Abstracts. (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Helmuth Gadner?

Helmuth Gadner is affiliated with the following schools: